Loading…

Atypical preeclampsia with systemic lupus erythematosus and elevated soluble fms‐like tyrosine kinase 1/placental growth factor ratio

While systemic lupus erythematosus is often complicated by preeclampsia, it is difficult to differentiate between its exacerbation and preeclampsia. The soluble fms‐like tyrosine kinase 1 (sFlt‐1)/placental growth factor (PlGF) ratio is unknown in systemic lupus erythematosus with preeclampsia befor...

Full description

Saved in:
Bibliographic Details
Published in:The journal of obstetrics and gynaecology research 2021-12, Vol.47 (12), p.4461-4466
Main Authors: Mimura, Kazuya, Tomimatsu, Takuji, Endo, Masayuki, Kimura, Tadashi
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:While systemic lupus erythematosus is often complicated by preeclampsia, it is difficult to differentiate between its exacerbation and preeclampsia. The soluble fms‐like tyrosine kinase 1 (sFlt‐1)/placental growth factor (PlGF) ratio is unknown in systemic lupus erythematosus with preeclampsia before 20 weeks of gestation. Three nulliparous women with systemic lupus erythematosus developed preeclampsia at 13, 13, and 17 weeks of gestation with sFlt‐1/PlGF ratios of 427, 865, and 525, respectively. Two patients terminated their pregnancies and delivered within 2 weeks, while one experienced intrauterine fetal death 4 weeks after the measurements. Their symptoms gradually improved, and all patients were discharged within 3 months. The sFlt‐1/PlGF ratio may be used in the differential diagnosis of preeclampsia and systemic lupus erythematosus exacerbation before 20 weeks of gestation.
ISSN:1341-8076
1447-0756
DOI:10.1111/jog.15055